who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

How Cigna (CI) makes money: Q3 2026 revenue breakdown

US GAAP, Q3 2026 · quarter ended 09/30/2026 · released Nov 5

Shareholders' net income

$1,442M

down 22.8% y/y

Total revenues

$73,683M

up 5.6% y/y

Income from operations

$2,396M

down 7.1% y/y

Next report

~ Feb 4

not announced yet

The quarter in brief

Total revenues rose 6% year over year to $73.7 billion in Q3 2026, while shareholders' net income fell to $1.4 billion, or $5.47 per diluted share, from $1.9 billion, or $6.98 per share.

Key growth driver: Pharmacy revenues — the fastest-growing revenue line: $58,982, +5% y/y. · by the Q3 2026 report

How does Cigna make money?

Cigna brought in $73.7 billion of revenue in Q3 2026, up 5.6% year over year. The largest source was Pharmacy revenues: $59.0 billion, or 80% of the total, followed by Premiums ($9.88B, 13%) and Fees and other revenues ($4.53B, 6%). Net income for the quarter was $1.44 billion, down 22.8% year over year.

Revenue by source, Q3 2026
  • Pharmacy revenues$59.0B · 80% · +5.2%
  • Premiums$9.88B · 13% · +8.9%
  • Fees and other revenues$4.53B · 6% · +3.4%
  • Net investment income$287M · 0.4% · +23.2%

Shares of $73.7B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.

All figures in $M.

Sankey diagram of CI (Cigna) earnings report for Q3 2026: revenue, costs and profitPharmacy revenues$58,982 · +5.2%Premiums$9,885 · +8.9%Fees and other revenues$4,529 · +3.4%Net investment income$287 · +23.2%Total revenues$73,683 · +5.6%Pharmacy andother servicecosts$58,590 · +5.5%Medical costs andother benefitexpenses$8,496 · +8.3%Selling, generalandadministrativeexpenses$3,612 · +7.4%Amortization ofacquiredintangible assets$589 · +35.1%Income fromoperations$2,396 · −7.1%3.3% marginInterest expenseand other$333 · −4.0%Net investmentgains$36 · +38.5%Income beforeincome taxes$2,099 · −8.5%Total income taxes$401 · +24.5%19.1% effective rateNet income attributable tononcontrolling interests$256 · +144%Shareholders' net income$1,442 · −22.8%$5.47/sh · 2.0% margin
Sankey diagram of CI (Cigna) earnings report for Q3 2026: revenue, costs and profit
Line itemAmount and change
Pharmacy revenues$58,982 · +5.2%
Premiums$9,885 · +8.9%
Fees and other revenues$4,529 · +3.4%
Net investment income$287 · +23.2%
Total revenues$73,683 · +5.6%
Pharmacy and other service costs$58,590 · +5.5%
Medical costs and other benefit expenses$8,496 · +8.3%
Selling, general and administrative expenses$3,612 · +7.4%
Amortization of acquired intangible assets$589 · +35.1%
Income from operations$2,396 · −7.1% · 3.3% margin
Interest expense and other$333 · −4.0%
Net investment gains$36 · +38.5%
Income before income taxes$2,099 · −8.5%
Total income taxes$401 · +24.5% · 19.1% effective rate
Net income attributable to noncontrolling interests$256 · +144%
Shareholders' net income$1,442 · −22.8% · $5.47/sh · 2.0% margin

Verdict: total revenues rose 6% year over year to $73.7 billion in Q3 2026, while shareholders' net income fell to $1.4 billion, or $5.47 per diluted share, from $1.9 billion, or $6.98 per share.

The Cigna Group raised its 2026 outlook for adjusted income from operations (non-GAAP) by $0.15 to at least $30.60 per share. Year to date through November 4, 2026, the company repurchased 1.8 million shares for approximately $500 million.

Source and notation

Source: CI Form 10-Q filed 11/05/2026 (SEC EDGAR); results date from the 8-K of 11/05/2026. The press release has no income statement, so the figures come from the 10-Q for the same quarter.

Open as an image: Cigna (CI), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “Cigna (CI) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/ci. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/ci"><img src="https://whoreportstoday.com/t/ci/img/ci-earnings-sankey.png" alt="Cigna (CI) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/ci">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/ci/img/ci-earnings-sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/ci">Cigna (CI) Q3 2026 earnings chart (Who Reports Today)</a>

The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. · Text: Wikipedia, CC BY-SA 4.0, abridged

Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.

Heads-up

Company reports

Q3 2026latest breakdownTotal revenues rose 6% year over year to $73.7 billion in Q3 2026, while shareholders' net income fell to $1.4 billion…
Q2 2026A huge-flow, thin-margin quarter working as designed — revenues +7% to $71.7B (pharmacy alone $57.2B), shareholders' net…

Company guidance

Same quarter a year ago (ended December 31, 2025): revenue $72.5B, EPS (GAAP) $4.64

How we calculate

Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.

CI earnings history: past report dates

Nov 5, 2026 Thu6:15 ambefore market openSep 30, 2026$73.7B+6% y/y$5.47−22% y/y
Jul 30, 2026 Thu6:16 ambefore market openJun 30, 2026$71.7B+7% y/y$6.29+10% y/y
Apr 30, 2026 Thu6:15 ambefore market openMar 31, 2026$68.5B+5% y/y$6.26+29% y/y
Feb 5, 2026 Thu6:15 ambefore market openDec 31, 2025≈$72.5B+10% y/y≈$4.64−7% y/y
Oct 30, 2025 Thu6:15 ambefore market openSep 30, 2025$69.7B+10% y/y$6.98+165% y/y
Jul 31, 2025 Thu6:15 ambefore market openJun 30, 2025$67.2B+11% y/y$5.71+5% y/y
May 2, 2025 Fri6:16 ambefore market openMar 31, 2025$65.5B+14% y/y$4.85
Jan 30, 2025 Thu6:15 ambefore market openDec 31, 2024≈$65.6B+28% y/y≈$5.01+44% y/y
Oct 31, 2024 Thu6:15 ambefore market openSep 30, 2024$63.7B+30% y/y$2.63−45% y/y
Aug 1, 2024 Thu6:15 ambefore market openJun 30, 2024$60.5B+25% y/y$5.45+11% y/y
May 2, 2024 Thu6:15 ambefore market openMar 31, 2024$57.3B+23% y/y−$0.97
Feb 2, 2024 Fri6:15 ambefore market openDec 31, 2023≈$51.1B+12% y/y≈$3.49−12% y/y
Nov 2, 2023 Thu6:16 ambefore market openSep 30, 2023$49.0B+8% y/y$4.74−47% y/y
Aug 3, 2023 Thu6:15 ambefore market openJun 30, 2023$48.6B+7% y/y$4.92+1% y/y
May 5, 2023 Fri6:15 ambefore market openMar 31, 2023$46.5B+6% y/y$4.24+14% y/y
Feb 3, 2023 Fri6:15 ambefore market openDec 31, 2022≈$45.8B+0% y/y≈$3.95+15% y/y
Show all 16 reports since 2023Show fewer
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

Cigna: 15-year financials

2025274,9009,2005,957—1,611
2024247,1219,4173,434—1,567
2023195,2658,5365,164—1,450
2022180,5188,4506,704—1,384
2021174,0697,9415,370—1,341
2020160,4018,1538,458—15
2019153,5668,0775,1048,43515
201848,6504,1602,6373,242—
201741,8063,9422,2373,615—
201639,8383,0881,8673,565—
201537,876—2,0942,423—
201434,914—2,1021,68511
201332,380—1,47619211
201229,119—1,6231,94211
201121,865—1,2601,06911

$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.

* Sources
How we calculate

Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. Dividends paid and share buybacks are actual annual cash payments from the cash flow statement, shown as positive cash outflows. Payments to noncontrolling interests and share-compensation withholding taxes are excluded. New values require three checks against issuer documents; unreviewed data is a dash and confirmed absence of payment is 0. Buybacks appear only when at least one reviewed payment exists in fifteen years. Updated after annual filings and document review. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.

Cigna: 15-year balance sheet

YearAssetsEquityDebtCashCurrent assetsCurrent liabilities
2025157,91941,71331,4637,67647,81456,342
2024155,88141,03332,8527,55048,87057,979
2023152,76146,22332,1677,82237,35148,716
2022143,88544,67531,0935,92430,12241,225
2021154,88947,11235,6975,08136,13443,572
2020155,45150,32133,94910,18227,79936,022
2019155,77445,33838,3514,61929,84540,138
2018153,22641,02841,0233,85520,43031,895
201761,75913,7115,5002,9729,31111,009
201659,36013,7235,0003,185——
201557,08812,0355,3001,968——
201455,87010,7745,3001,420——
201354,33610,5675,3002,795——
201253,7349,7695,4002,978——
201150,6977,9945,0904,690——

$ millions, at fiscal year-end*.

* Sources
How we calculate

Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .

Cash flow

9 months ended 2026-09-30 · $M

LineThis periodYear agoΔ
Operating cash flowcash the business generated3,2813,452−171
· incl. D&A (non-cash add-back)depreciation & amortization2,1722,053
Investing activities, netcapex, acquisitions, securities−2,414−3,987+1,573
· incl. acquisitionsbusinesses net of cash acquired0−597+597
Financing activities, netdebt, buybacks, dividends−2,376−2,355−21
· incl. buybacksrepurchases of common stock−531−2,620+2,089
· incl. dividends paid−1,236−1,215−21
Net change in cash−1,524−2,860+1,336
How to read the table

Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.

Bank or insurer: CAPEX and FCF do not apply to this business model — “—”.

Shareholders’ equity at Sep 30, 2026: $43.4B (28% of total assets). Compare with other S&P 500 companies →

Corporate governance

2/2good

  • Feb 202610-K FY2025 cover: a single class of common stock; the legal section shows no shareholder disclosure suits or SEC cases. sec.gov ↗
  • Feb 2026Diluted shares 368.4M (2020) → 268.6M (2025), −27%; dividend $4.00 (2021) → $6.04 (2025). data.sec.gov ↗
1 more fact and scoring

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

  • Mar 20262026 proxy: no related-party transactions in 2025. sec.gov ↗

Scoring: 2.0, no deductions: single share class, diluted shares −27% over 5 years, dividend raised from $0.04 to $6.04 and growing, no shareholder suits or SEC cases in 10 years; False Claims Act penalties are industry matters

Share classes
Single class of common stock (NYSE: CI).
Dilution
Diluted shares 368.4M (2020) → 268.6M (2025), −27%; SBC 0.1% of revenue.
Disclosure
Full reporting.
Dividends
Since 2021 the dividend went from $4.00 → $6.04 (2025) per share, raised every year.
Lawsuits & regulators
10-K FY2025: FTC disputes (settled in Feb 2026 with no penalty) and industry investigations; no shareholder suits or SEC cases; the 2002 shareholder suit ($93M, 2007) is older than 10 years and a single episode — does not change the score.
Related parties
No related-party transactions requiring disclosure in 2025 (2026 proxy).

How the score works · checked as of Oct 2026

Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · Piotroski F-score: S&P 500 companies scoring 8 or 9

Cigna (CI) earnings: FAQ

How does Cigna make money?

Cigna brought in $73.7 billion of revenue in Q3 2026, up 5.6% year over year. The largest source was Pharmacy revenues: $59.0 billion, or 80% of the total, followed by Premiums ($9.88B, 13%) and Fees and other revenues ($4.53B, 6%). Net income for the quarter was $1.44 billion, down 22.8% year over year.

When is CI's next earnings date?

We have not yet seen an announcement of the date from Cigna (CI). Based on last year's report on Feb 5, 2026, the next report is expected around Feb 4, 2027.

What time does CI report earnings?

Cigna usually reports before market open: its latest results release was filed with the SEC at 6:15 am ET on Nov 5, 2026.

When did CI last report earnings?

Cigna reported Q3 2026 results on Nov 5, 2026.

Where can I find Cigna's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CI's filings; this page breaks the latest report down in a Sankey chart.

What was CI's net income in Q3 2026?

Cigna reported net income of $1,442M for Q3 2026 (−22.8% year over year), under US GAAP.

Does Cigna pay dividends?

Yes. In 2025, Cigna paid $1,611M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.

How has Cigna's revenue changed since 2011?

Per its 10-K filings, revenue grew 12.6x: $21,865M in 2011 and $274,900M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.

New to earnings reports? Start with how to read an earnings report.

Get it every Monday: who reports this week

Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.

Only dates announced by companies. No stock prices. Not investment advice.

More reports: CNC · Q3 2026 · COO · Q3 FY2026 · COR · Q4 FY2026 · CRL · Q3 2026 · CVS · Q3 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · all reports

Cookies the site needs and, with your consent, Google Analytics — privacy policy